Blog RSS



World-Known Star of Exelead, Alex Aust Joins T&T Scientific to Help the Company become the Leader of Pharmaceutical Lipid Nanoparticles Formulations, and Manufacturing (After Four Months of Original Publication)

I would like to share this great news again after four months already, how fortunate we are to have you Alexander K. Aust, MS, MBA. Alex is not only a very knowledgeable and experienced person in the field of RNA therapeutics and vaccines manufacturing, but he is a "TEAM PLAYER" that I have never previously seen even close to. One more thing about Alex, I have been astounded by, is Alex's all-around capabilities which are truly impressive, things I would never expect (Contradictory a lot of times)!! Thank you for all your commitment to T&T Scientific Corporation's success, and we see your impact more and more every day. -Nima Tamaddoni - Aug 23, 2021   April 26th, 2021 World-Known Star of Exelead,...

Continue reading



Cationic and Ionizable Lipid Nanoparticles for Gene Therapy and Vaccine Applications

Cationic and Ionizable Lipid Nanoparticles for Gene Therapy and Vaccine Applications Author: Nima Tamaddoni, PhD 13th August 2021 Download PDF Cationic and Ionizable Lipid Nanoparticles for Gene Therapy and Vaccine Applications Nima Tamaddoni, Ph.D.T&T Scientific Corporation, Knoxville, TN 37918 USA New generations of lipid nanocarriers, including solid lipid nanoparticles, cationic lipid-nucleic acid complexes, and nanostructured lipid carriers, are physically more stable and complex than previous nanoparticles used. Delivery time can be controlled with these lipid nanoparticles (Guevara et al., 2020). COVID-19 vaccines development in a brief period would not have been possible if we had not spent decades researching nanoparticles. Lipid nanoparticles are being used to treat cancer before and now are the main component of mRNA vaccines for COVID-19....

Continue reading